It’s Time: The Life Raft Group Biomarker Testing Campaign – Precise Diagnosis
It's time to to recognize the value of a more precise diagnosis. GISTer Jon Treder shares his story.
It's time to to recognize the value of a more precise diagnosis. GISTer Jon Treder shares his story.
The Life Raft Group is delighted to welcome two phenomenal new members to our Board of Directors: Ms. Kay Stolzer and Dr. Monica (mOe) Anderson.
It's time to fully unleash the power of biomarker testing to support precision oncology - all GIST patients should have biomarker (mutational) testing for the best possible personalized treatment plan.
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Vicenta Salinas shares her story.
Understanding the role of mutations and biomarker testing is one of most important things patients must learn. Uncovering the driving force behind each individual’s tumors is not just important, it is critical. This video shows the action steps of our It's Time campaign.
Lea el artículo para Colectivo GIST España sobre la importancia de conocer la mutación de tu gist - succinato deshidrogenasa - Abril 8, 2021
Abril 6, 2021 No nos cansamos de decirlo: la importancia de conocer la mutación de tu gist para optimizar y personalizar el tratamiento El análisis de las mutaciones es probablemente un factor [...]
We took some time to reflect on all we have done virtually as an organization throughout the year. In the midst of this reflection, we wanted to take a breath and say a special thank you to our Major Donors.
This video contains information about Gastrointestinal Stromal Tumor (GIST) presented by Dr. Sameer Rastogi, All India Institute of Medical Sciences, New Delhi, India.
This video deals with the mechanism of avapritinib in GIST, current outcomes and challenges with PDGFRA D842V mutated GIST presented by Dr. Sameer Rastogi, All India Institute of Medical Sciences, New Delhi, India..